The ketogenic diet: Uses in epilepsy and other neurologic illnesses

Opinion statementThe ketogenic diet is well established as therapy for intractable epilepsy. It should be considered first-line therapy in glucose transporter type 1 and pyruvate dehydrogenase deficiency. It should be considered early in the treatment of Dravet syndrome and myoclonic-astatic epilepsy (Doose syndrome).Initial studies indicate that the ketogenic diet appears effective in other metabolic conditions, including phosphofructokinase deficiency and glycogen osis type V (McArdle disease). It appears to function in these disorders by providing an alternative fuel source. A growing body of literature suggests the ketogenic diet may be beneficial in certain neurodegenerative diseases, including Alzheimer disease, Parkinson’s disease, and amyotrophic lateral sclerosis. In these disorders, the ketogenic diet appears to be neuroprotective, promoting enhanced mitochondrial function and rescuing adenosine triphosphate production.Dietary therapy is a promising intervention for cancer, given that it may target the relative inefficiency of tumors in using ketone bodies as an alternative fuel source. The ketogenic diet also may have a role in improving outcomes in trauma and hypoxic injuries.

[1]  P. Huttenlocher Ketonemia and Seizures: Metabolic and Anticonvulsant Effects of Two Ketogenic Diets in Childhood Epilepsy , 1976, Pediatric Research.

[2]  K. Swaiman,et al.  Early biochemical and EEG correlates of the ketogenic diet in children with atypical absence epilepsy. , 1985, Pediatric neurology.

[3]  L. Nebeling,et al.  Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. , 1995, Journal of the American College of Nutrition.

[4]  S. Dimauro,et al.  Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. , 1997, The Journal of pediatrics.

[5]  D. Kerr,et al.  Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets , 1997, Neurology.

[6]  K. Clarke,et al.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. A. Yamada,et al.  Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.

[8]  P. Pyzik,et al.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. , 2001, Pediatrics.

[9]  Y. Ishibashi,et al.  Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats , 2002, Journal of neurochemistry.

[10]  J. Rho,et al.  Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in l‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo , 2002, Epilepsia.

[11]  M. Funatsuka,et al.  Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood , 2002, Neuropediatrics.

[12]  J. Smeitink,et al.  Application of a Ketogenic Diet in Children With Autistic Behavior: Pilot Study , 2003, Journal of child neurology.

[13]  M. Vila,et al.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.

[14]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[15]  W. Yancy,et al.  Diet therapy for narcolepsy , 2004, Neurology.

[16]  W. Burnham,et al.  The antidepressant properties of the ketogenic diet , 2004, Biological Psychiatry.

[17]  Richard E. Carson,et al.  Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Henderson,et al.  High carbohydrate diets and Alzheimer's disease. , 2004, Medical hypotheses.

[19]  F. van Leuven,et al.  A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease , 2005, Nutrition & metabolism.

[20]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[21]  K. Gempel,et al.  Treatment of glycogenosis type V with ketogenic diet , 2005, Annals of neurology.

[22]  E. Thiele,et al.  The use of diet in the treatment of epilepsy , 2005, Epilepsy & Behavior.

[23]  Hong Yang,et al.  Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects , 2005, Annals of neurology.

[24]  D. Hovda,et al.  Age‐dependent reduction of cortical contusion volume by ketones after traumatic brain injury , 2005, Journal of neuroscience research.

[25]  D. MacGrogan,et al.  A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.

[26]  S. B. Heymsfield,et al.  Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study , 2005, Neurology.

[27]  T. Seyfried,et al.  Targeting energy metabolism in brain cancer: review and hypothesis , 2005, Nutrition & metabolism.

[28]  N. Fejerman,et al.  Ketogenic diet in patients with myoclonic-astatic epilepsy. , 2006, Epileptic disorders : international epilepsy journal with videotape.

[29]  J. Perlmutter,et al.  Reply from the Authors [12] , 2006 .

[30]  R. S. Strahlman,et al.  Can Ketosis Help Migraine Sufferers? A Case Report , 2006, Headache.

[31]  Y. Smith,et al.  Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet , 2006, Annals of neurology.

[32]  E. Vining,et al.  The Outcome of Children with Intractable Seizures: A 3‐ to 6‐Year Follow‐up of 67 Children Who Remained on the Ketogenic Diet Less Than One Year , 2006, Epilepsia.

[33]  Avtar Roopra,et al.  2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP–dependent metabolic regulation of chromatin structure , 2006, Nature Neuroscience.

[34]  G. Ronnett,et al.  Developing a head for energy sensing: AMP‐activated protein kinase as a multifunctional metabolic sensor in the brain , 2006, The Journal of physiology.

[35]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[36]  Jun Wang,et al.  Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.

[37]  E. Perucca,et al.  The Ketogenic diet: from molecular mechanisms to clinical effects , 2006, Epilepsy Research.

[38]  D. Truong,et al.  Ketogenic diet prevents seizure and reduces myoclonic jerks in rats with cardiac arrest-induced cerebral hypoxia , 2007, Neuroscience Letters.

[39]  J. Rho,et al.  Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.

[40]  J. L. Stringer,et al.  Fructose-1,6-Bisphosphate Has Anticonvulsant Activity in Models of Acute Seizures in Adult Rats , 2007, The Journal of Neuroscience.

[41]  R. Wittig,et al.  Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides , 2008, BMC Cancer.

[42]  J. Rho,et al.  Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.

[43]  J. Rho,et al.  Anticonvulsant Mechanisms of the Ketogenic Diet , 2007, Epilepsia.

[44]  H. Dashti,et al.  Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia , 2007, Acta cardiologica.

[45]  M. Kiebish,et al.  The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer , 2007, Nutrition & metabolism.

[46]  G. Yellen,et al.  Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening KATP Channels , 2007, The Journal of Neuroscience.

[47]  C. Korff,et al.  Dravet Syndrome (Severe Myoclonic Epilepsy in Infancy): A Retrospective Study of 16 Patients , 2007, Journal of child neurology.

[48]  J. LaManna,et al.  Diet-induced ketosis increases capillary density without altered blood flow in rat brain. , 2007, American journal of physiology. Endocrinology and metabolism.

[49]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[50]  S. Pizzo,et al.  Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis , 2008, The Prostate.

[51]  L. Guarente Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins? , 2008, Cell.

[52]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[53]  D. Truong,et al.  Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration , 2008, Journal of Neural Transmission.

[54]  E. Kossoff,et al.  A case‐control evaluation of the ketogenic diet versus ACTH for new‐onset infantile spasms , 2008, Epilepsia.